GREENVILLE, S.C. (FOX Carolina) - Two Greenville families are navigating one of the rarest diagnoses a parent can receive — and they are doing it together. Both families learned their sons had Hunter ...
A Denali Therapeutics drug for the rare enzyme deficiency Hunter syndrome is still in pivotal testing, but the company has guidance from the FDA on a pathway to get this therapy to the market sooner.
The U.S. Food and Drug Administration has agreed to reconsider Regenxbio’s application for its experimental gene therapy Navsunli.
JCR Pharma’s Izcargo, a blood-brain barrier-penetrating ERT for Hunter syndrome receives UAE marketing authorization: Hyogo, Japan Thursday, July 23, 2026, 14:00 Hrs [IST] JCR P ...
A breakthrough drug treating a rare genetic disorder is giving families new hope. Roran Jaskulski, 6, is among the first in the country to receive the treatment AVLAYAH. Children's Wisconsin is the ...
After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is climbing closer to its goal of accelerated approval by unveiling data ...
The UK regulatory authorities have approved the first ever trial of a revolutionary gene therapy for young children diagnosed with Hunter syndrome, a devastating rare lysosomal storage disorder. Five ...
Add Yahoo as a preferred source to see more of our stories on Google. A child with Hunter Syndrome has amazed doctors with his progress after becoming the first person in the world to receive a ...
The first-ever Hoops for Hunter Syndrome will take place July 19 in Chino. Ricky Chu and Dr. Raymond Wang talk more about the ...
Denali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, tividenofusp alfa (DNL310), for the treatment of individuals with Hunter ...
Denali Therapeutics Inc. announced positive long-term data from its Phase 1/2 study of tividenofusp alfa (DNL310) in patients with Hunter syndrome (MPS II), showing sustained reductions in key disease ...